Cara Therapeutics (CARA) Short Interest Ratio & Short Volume $0.28 -0.01 (-3.68%) (As of 12:09 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cara Therapeutics Short Interest DataCara Therapeutics (CARA) has a short interest of 1.26 million shares, representing 2.75% of the float (the number of shares available for trading by the public). This marks a 33.69% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 640,842 shares to cover all short positions.Current Short Interest1,260,000 sharesPrevious Short Interest942,500 sharesChange Vs. Previous Month+33.69%Dollar Volume Sold Short$391,986.00Short Interest Ratio2.5 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares54,860,000 sharesFloat Size45,770,000 sharesShort Percent of Float2.75%Today's Trading Volume363,378 sharesAverage Trading Volume640,842 sharesToday's Volume Vs. Average57% Short Selling Cara Therapeutics? Sign up to receive the latest short interest report for Cara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCARA Short Interest Over TimeCARA Days to Cover Over TimeCARA Percentage of Float Shorted Over Time Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Cara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20241,260,000 shares $391,986.00 +33.7%2.8%2.5 $0.31 10/31/2024942,500 shares $292,552.00 +54.6%2.1%2 $0.31 10/15/2024609,700 shares $155,473.50 -26.7%1.3%1.9 $0.26 9/30/2024832,200 shares $256,317.60 -31.2%1.8%1.6 $0.31 9/15/20241,210,000 shares $317,625.00 +9.0%2.6%1.7 $0.26 8/31/20241,110,000 shares $399,600.00 -24.0%2.4%1.3 $0.36 Get the Latest News and Ratings for CARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/20241,460,000 shares $474,500.00 +73.2%3.2%1.7 $0.33 7/31/2024842,900 shares $293,413.49 +37.4%1.9%1 $0.35 7/15/2024613,400 shares $205,489.00 -68.2%1.4%0.7 $0.34 6/30/20241,930,000 shares $497,940.00 -15.0%4.2%2.8 $0.26 6/15/20242,270,000 shares $794,500.00 -1.3%5.0%3.9 $0.35 5/31/20242,300,000 shares $1.49 million -5.7%5.1%6 $0.65 5/15/20242,440,000 shares $1.85 million -6.5%5.2%4.4 $0.76 4/30/20242,610,000 shares $1.96 million No Change5.6%4.4 $0.75 4/15/20242,610,000 shares $1.85 million +1.2%5.6%4.1 $0.71 3/31/20242,580,000 shares $2.35 million +4.0%5.6%3.7 $0.91 3/15/20242,480,000 shares $2.18 million +3.8%5.3%3.1 $0.88 2/29/20242,390,000 shares $2.03 million +7.2%5.2%2.5 $0.85 2/15/20242,230,000 shares $1.33 million -11.2%4.8%2.5 $0.60 1/31/20242,510,000 shares $1.42 million +5.5%5.4%3.2 $0.57 1/15/20242,380,000 shares $1.36 million +3.0%5.1%3.1 $0.57 12/31/20232,310,000 shares $1.72 million +6.5%5.0%3.1 $0.74 12/15/20232,170,000 shares $2.67 million -38.9%4.7%3.2 $1.23 11/30/20233,550,000 shares $3.43 million +3.8%7.7%6.2 $0.97 11/15/20233,420,000 shares $3.83 million +15.2%7.4%5.6 $1.12 10/31/20232,970,000 shares $3.83 million +9.6%6.6%5 $1.29 10/15/20232,710,000 shares $3.85 million +9.7%6.0%4.1 $1.42 9/30/20232,470,000 shares $4.15 million +10.3%5.5%3.5 $1.68 9/15/20232,240,000 shares $5.24 million +44.5%5.0%2 $2.34 8/31/20231,550,000 shares $3.98 million -40.8%3.5%1.2 $2.57 8/15/20232,620,000 shares $7.86 million -24.5%5.8%1.9 $3.00 7/31/20233,470,000 shares $11.56 million -12.6%8.1%2.5 $3.33 7/15/20233,970,000 shares $11.35 million +6.7%9.3%2.9 $2.86 6/30/20233,720,000 shares $10.53 million -35.3%8.7%2.8 $2.83 6/15/20235,750,000 shares $18.57 million +12.5%13.5%5.9 $3.23 5/31/20235,110,000 shares $16.25 million +2.0%12.0%6.8 $3.18 5/15/20235,010,000 shares $20.79 million No Change11.7%6.8 $4.15 4/30/20235,010,000 shares $21.04 million +3.5%11.9%7.5 $4.20 4/15/20234,840,000 shares $20.47 million -9.4%11.4%7.5 $4.23 3/31/20235,340,000 shares $26.22 million +3.9%12.6%8.6 $4.91Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 3/15/20235,140,000 shares $29.61 million -6.4%12.2%8.7 $5.76 2/28/20235,490,000 shares $55.78 million -1.4%13.0%11 $10.16 2/15/20235,570,000 shares $57.71 million +3.9%13.3%15.2 $10.36 1/31/20235,360,000 shares $62.60 million +6.4%12.8%15.3 $11.68 1/15/20235,040,000 shares $54.68 million +1.6%12.0%14.1 $10.85 12/30/20224,960,000 shares $53.27 million -10.8%11.8%13.8 $10.74 12/15/20225,560,000 shares $62.11 million -0.4%13.2%16.4 $11.17 11/30/20225,580,000 shares $65.84 million -9.4%13.3%16.5 $11.80 11/15/20226,160,000 shares $69.79 million -1.8%14.7%18.1 $11.33 10/31/20226,270,000 shares $58.94 million -1.7%14.9%17.1 $9.40 10/15/20226,380,000 shares $64.82 million -3.6%15.2%16.4 $10.16 9/30/20226,620,000 shares $61.96 million -7.2%15.8%16.4 $9.36 9/15/20227,130,000 shares $73.65 million No Change17.0%16.5 $10.33 8/31/20227,130,000 shares $73.58 million -0.7%17.0%16.4 $10.32 8/15/20227,180,000 shares $84.37 million -0.8%17.1%15.1 $11.75 7/31/20227,240,000 shares $63.28 million +3.0%16.3%12.6 $8.74 7/15/20227,030,000 shares $65.03 million +8.2%15.8%11.4 $9.25 6/30/20226,500,000 shares $59.35 million +3.5%14.6%10 $9.13 6/15/20226,280,000 shares $49.86 million +3.6%14.1%9.8 $7.94 5/31/20226,060,000 shares $50.42 million +13.3%13.6%9.1 $8.32 5/15/20225,350,000 shares $44.94 million +30.2%12.0%7.8 $8.40 4/30/20224,110,000 shares $35.84 million -2.4%9.2%6.9 $8.72 4/15/20224,210,000 shares $58.27 million +2.9%9.5%7.7 $13.84 3/31/20224,090,000 shares $49.69 million +1.0%9.2%8.2 $12.15 3/15/20224,050,000 shares $46.37 million +29.4%9.1%8.4 $11.45 2/28/20223,130,000 shares $32.46 million +25.2%7.1%6.3 $10.37 2/15/20222,500,000 shares $26.43 million +50.6%5.7%5.1 $10.57 1/31/20221,660,000 shares $19.22 million -4.6%3.8%3.2 $11.58 1/15/20221,740,000 shares $20.79 million -7.0%N/A0 $11.95 12/31/20211,870,000 shares $22.78 million -9.7%4.2%2.8 $12.18 12/15/20212,070,000 shares $25.83 million -19.8%4.7%3.1 $12.48 11/30/20212,580,000 shares $34.00 million +4.5%5.9%3.7 $13.18 11/15/20212,470,000 shares $38.63 million -14.8%5.6%2.7 $15.64 10/29/20212,900,000 shares $48.81 million +37.4%7.3%1.8 $16.83 10/15/20212,110,000 shares $27.77 million -0.5%5.3%1.4 $13.16 9/30/20212,120,000 shares $32.75 million -30.3%5.3%1.4 $15.45 9/15/20213,040,000 shares $44.90 million -21.5%7.6%2 $14.77 8/31/20213,870,000 shares $61.07 million +29.4%9.6%2.6 $15.78 8/13/20212,990,000 shares $41.41 million -2.0%7.4%4.3 $13.85 7/30/20213,050,000 shares $36.51 million No Change7.8%5.4 $11.97 7/15/20213,050,000 shares $39.47 million -3.8%7.8%3.6 $12.94 6/30/20213,170,000 shares $45.24 million -10.5%8.1%3.4 $14.27 6/15/20213,540,000 shares $50.20 million +12.4%9.0%2.8 $14.18 5/28/20213,150,000 shares $42.81 million -11.8%8.0%2.5 $13.59 5/14/20213,570,000 shares $45.98 million -7.8%9.1%2.9 $12.88 4/30/20213,870,000 shares $54.45 million +8.1%9.9%3 $14.07 4/15/20213,580,000 shares $102.10 million +30.7%9.3%3.8 $28.52 3/31/20212,740,000 shares $56.42 million -14.6%7.1%3.1 $20.59 3/15/20213,210,000 shares $61.95 million +4.6%8.3%6.3 $19.30 2/26/20213,070,000 shares $59.13 million +9.6%7.9%6.1 $19.26Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/12/20212,800,000 shares $55.75 million -4.4%7.2%5.8 $19.91 1/29/20212,930,000 shares $54.15 million -18.2%7.6%6.5 $18.48 1/15/20213,580,000 shares $64.62 million -6.8%9.2%8.2 $18.05 12/31/20203,840,000 shares $59.06 million -3.0%9.9%9.3 $15.38 12/15/20203,960,000 shares $59.00 million +2.9%10.2%9.3 $14.90 11/30/20203,850,000 shares $57.56 million +0.5%9.9%9.1 $14.95 11/15/20203,830,000 shares $59.02 million No Change10.1%9.3 $15.41 10/30/20203,830,000 shares $50.44 million -15.3%10.7%9.8 $13.17 10/15/20204,520,000 shares $60.52 million +2.5%12.6%11.6 $13.39 9/30/20204,410,000 shares $56.12 million +14.8%10.3%11.7 $12.73 9/15/20203,840,000 shares $58.56 million +2.4%9.0%10.3 $15.25 8/31/20203,750,000 shares $58.13 million +2.7%8.8%9.3 $15.50 8/14/20203,650,000 shares $59.46 million -1.1%8.5%8.5 $16.29 7/31/20203,690,000 shares $60.66 million -3.2%8.7%7.6 $16.44 7/15/20203,810,000 shares $68.28 million -5.0%9.0%7.4 $17.92 6/30/20204,010,000 shares $67.29 million +12.0%9.5%7.4 $16.78 6/15/20203,580,000 shares $55.56 million -2.2%8.5%6.6 $15.52 5/29/20203,660,000 shares $58.08 million -2.1%8.6%6.7 $15.87 5/15/20203,740,000 shares $56.25 million +14.0%8.8%6.6 $15.04 4/30/20203,280,000 shares $48.61 million -6.0%7.7%6.4 $14.82 4/15/20203,490,000 shares $48.62 million -5.4%8.2%6.8 $13.93 3/31/20203,690,000 shares $58.45 million -13.2%8.7%6.9 $15.84 3/13/20204,251,500 shares $58.54 million -1.6%12.2%8.2 $13.77 2/28/20204,320,000 shares $47.78 million +0.2%12.4%7.2 $11.06 2/14/20204,310,000 shares $60.25 million -5.5%10.2%5.9 $13.98 1/31/20204,560,000 shares $72.32 million -6.0%10.7%6.2 $15.86 1/15/20204,850,000 shares $83.81 million -9.7%11.4%6.6 $17.28 12/31/20195,370,000 shares $86.19 million -0.7%12.7%7.9 $16.05 CARA Short Interest - Frequently Asked Questions What is Cara Therapeutics' current short interest? Short interest is the volume of Cara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 1,260,000 shares of CARA short. 2.75% of Cara Therapeutics' shares are currently sold short. Learn More on Cara Therapeutics' current short interest. What is a good short interest ratio for Cara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARA shares currently have a short interest ratio of 2.0. Learn More on Cara Therapeutics's short interest ratio. What is a good short interest percentage for Cara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.75% of Cara Therapeutics' floating shares are currently sold short. Is Cara Therapeutics' short interest increasing or decreasing? Cara Therapeutics saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,260,000 shares, an increase of 33.7% from the previous total of 942,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cara Therapeutics' float size? Cara Therapeutics currently has issued a total of 54,860,000 shares. Some of Cara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cara Therapeutics currently has a public float of 45,770,000 shares. How does Cara Therapeutics' short interest compare to its competitors? 2.75% of Cara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cara Therapeutics: AlloVir, Inc. (1.06%), Cellectar Biosciences, Inc. (2.90%), Aileron Therapeutics, Inc. (0.92%), CervoMed Inc. (31.21%), Iterum Therapeutics plc (10.30%), Spero Therapeutics, Inc. (1.00%), Entera Bio Ltd. (0.15%), InterCure Ltd. (0.06%), IO Biotech, Inc. (0.19%), CASI Pharmaceuticals, Inc. (1.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Cara Therapeutics stock? Short selling CARA is an investing strategy that aims to generate trading profit from Cara Therapeutics as its price is falling. CARA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cara Therapeutics? A short squeeze for Cara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARA, which in turn drives the price of the stock up even further. How often is Cara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARA, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies ALVR Short Interest CLRB Short Interest ALRN Short Interest CRVO Short Interest ITRM Short Interest SPRO Short Interest ENTX Short Interest INCR Short Interest IOBT Short Interest CASI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CARA) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
